Panbela Therapeutics Inc. buy Roth Mkm
Start price
05.02.24
/
50%
€90.36
Target price
05.02.25
€23.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 05.02.25. The prediction end date can be changed by Roth_Mkm at any time.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Panbela Therapeutics Inc. | - | - |
iShares Core DAX® | 2.275% | 4.627% |
iShares Nasdaq 100 | 6.015% | 2.007% |
iShares Nikkei 225® | 4.456% | 3.598% |
iShares S&P 500 | 4.061% | 2.876% |
Comments by Roth_Mkm for this prediction
In the thread Panbela Therapeutics Inc. diskutieren
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its price target lowered by analysts at Roth Mkm from $500.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for PBLA provided by MarketBeat
Stopped prediction by Roth_Mkm for Panbela Therapeutics Inc.
Panbela Therapeutics Inc.
Start price
Target price
Perf. (%)
€90.36
27.03.24
27.03.24
€23.10
27.03.25
27.03.25
-
15.12.23
15.12.23
Panbela Therapeutics Inc.
Start price
Target price
Perf. (%)
€90.36
18.12.23
18.12.23
€22.90
18.12.24
18.12.24
-
15.12.23
15.12.23